AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

GENETIC SIGNATURES LTD

0.075

+0.0022.74%

Volume:424.64K

Turnover:33.08K

Market Cap:17.04M

PE:-1.53

High:0.078

Open:0.075

Low:0.075

Close:0.073

52wk High:0.430

52wk Low:0.051

Shares:227.14M

Float Shares:188.02M

Volume Ratio:3.29

T/O Rate:0.23%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.049

EPS(LYR):-0.089

ROE:-22.84%

ROA:-14.12%

PB:0.39

PE(LYR):-0.85

Loading ...

Overview Company News Filings

Concept

Novel Coronavirus Treatment+1.70%

Capital Flow

Inflow:

Outflow:

News

Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln

THOMSON REUTERS

Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark

THOMSON REUTERS

BCAL to Acquire Shares in Genetic Signatures

Genetic Signatures Ltd - Genetic Signatures is not in a Position to Comment on Bcal's Intentions Beyond Statements Contained in Bcal's Announcement

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/stock/GSS.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","market":"AU","secType":"STK","nameCN":"GENETIC SIGNATURES LTD","latestPrice":0.075,"timestamp":1787621895700,"preClose":0.073,"halted":0,"volume":424641,"delay":0,"changeRate":0.02739726027397263,"nameEN":"GENETIC SIGNATURES LTD","floatShares":188016272,"shares":227138828,"eps":-0.049055,"marketStatus":"Trading","change":0.002,"latestTime":"08-25 11:54:57 AEST","open":0.075,"high":0.078,"low":0.075,"amount":33079,"amplitude":0.041096,"askPrice":0.079,"askSize":18461,"bidPrice":0.075,"bidSize":40234,"shortable":3,"etf":0,"ttmEps":-0.049055,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787637600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.073,"openAndCloseTimeList":[[1787616000000,1787637600000]],"volumeRatio":3.2873,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"GSS.AU","preClose":0.068,"auctionPrice":0.068,"auctionVolume":29329,"auction":3,"marketStatus":"盘后竞价","timestamp":1787551200777}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"GSS.AU\",,,,,undefined,":{"symbol":"GSS.AU","floatShares":188016272,"roa":"-14.12%","roe":"-22.84%","lyrEps":-0.088679,"volumeRatio":3.2873,"shares":227138828,"dividePrice":0,"high":0.078,"amplitude":0.041096,"preClose":0.073,"low":0.075,"week52Low":0.051,"pbRate":"0.39","psRate":"0.85","week52High":0.43,"institutionHeld":0,"latestPrice":0.075,"committee":0.370952,"eps":-0.049055,"divideRate":0,"volume":424641,"delay":0,"ttmEps":-0.049055,"open":0.075,"prevYearClose":0.25,"prevWeekClose":0.068,"prevMonthClose":0.059,"prevQuarterClose":0.067,"fiveDayClose":0.061,"twentyDayClose":0.06,"sixtyDayClose":0.072,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787616000000,"name":null,"time":"","dateTimestamp":1787580000000,"actualEps":null},{"date":"2026-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-08-25","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756080000000,"name":null,"time":"","dateTimestamp":1756044000000,"actualEps":null},{"date":"2025-02-26","symbol":"GSS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"market":"AU","date":"2023-12-27","symbol":"GSS.AU","defaultRemindTime":1703631600000,"type":"split","dateTimestamp":1703595600000,"forFactor":976761,"toFactor":1000000,"ratio":0.9767610000000001}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSS.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662048712","title":"Genetic Signatures Ltd - FY Revenues from Ordinary Activities A$14.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662048712","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662048712?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:15","pubTimestamp":1787613347,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0UW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661258927","title":"Genetic Signatures Ltd-Commercial Testing Commences at Hvidovre Hospital in Denmark","url":"https://stock-news.laohu8.com/highlight/detail?id=2661258927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661258927?lang=en_us&edition=fundamental","pubTime":"2026-08-21 07:26","pubTimestamp":1787268401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nTUE50GHHT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7048","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649446988","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2649446988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649446988?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:38","pubTimestamp":1783413518,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - BCAL Diagnostics Ltd::*BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSS*TO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLION*Further company coverage: BDX.AX* ((Reuters.Brief","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDXrYJs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7501","GSS.AU","BK7067","BK7048","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648579366","title":"Genetic Signatures Ltd - Genetic Signatures is not in a Position to Comment on Bcal's Intentions Beyond Statements Contained in Bcal's Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2648579366","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648579366?lang=en_us&edition=fundamental","pubTime":"2026-07-02 12:41","pubTimestamp":1782967278,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN433100:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7501","GSS.AU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GSS.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Novel Coronavirus Treatment","id":"package_au_concept_xgzlg","bkCode":"BK7501","changeRate":0.017042}]}}